Mouse models orthologous to FGFR3-related skeletal dysplasias

被引:16
作者
Brodie, SG [1 ]
Deng, CX [1 ]
机构
[1] NIDDK, Genet Dev & Dis Branch, NIH, Bethesda, MD 20892 USA
来源
PEDIATRIC PATHOLOGY & MOLECULAR MEDICINE | 2003年 / 22卷 / 01期
关键词
achondroplasia; FGFR3; gene targeting; hypochondroplasia; mouse models; skeletal development; skeletal dysplasia; thanatophoric dysplasia;
D O I
10.1080/15227950307697
中图分类号
R36 [病理学];
学科分类号
100104 [病理学与病理生理学];
摘要
Fibroblast growth factor receptor 3 (FGFR3) is one of the membrane bound tyrosine kinases that mediate the actions of fibroblast growth factor (FGF) family members. Missense mutations in the coding regions of FGFR3 have been identified in allelic forms of short-limbed dwarfism. Using gene targeting, we demonstrated that Fgfr3 plays an essential role in endochondral ossification and that a loss-of-function mutation causes accelerated and prolonged long bone growth. Using a number of molecular genetic approaches, we also have introduced into the mouse genome a series of mutations that correspond to the missense mutations identified in individuals with achondroplasia and thanatophoric dysplasia. These mouse models mimic the human condition and can be used for further studies to identify and characterize in vivo changes associated with various Fgfr3 mutations. In additions, these models may be beneficial in future studies to attempt novel treatment strategies for short-limbed dwarfism.
引用
收藏
页码:87 / 103
页数:17
相关论文
共 69 条
[1]
Targeted disruption of fibroblast growth factor (FGF) receptor 2 suggests a role for FGF signaling in pregastrulation mammalian development [J].
Arman, E ;
Haffner-Krausz, R ;
Chen, Y ;
Heath, JK ;
Lonai, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (09) :5082-5087
[2]
Mammalian skeletogenesis and extracellular matrix:: What can we learn from knockout mice? [J].
Aszódi, A ;
Bateman, JF ;
Gustafsson, E ;
Boot-Handford, R ;
Fässler, R .
CELL STRUCTURE AND FUNCTION, 2000, 25 (02) :73-84
[3]
A NOVEL FORM OF FGF RECEPTOR-3 USING AN ALTERNATIVE EXON IN THE IMMUNOGLOBULIN DOMAIN-III [J].
AVIVI, A ;
YAYON, A ;
GIVOL, D .
FEBS LETTERS, 1993, 330 (03) :249-252
[4]
THE FGF FAMILY OF GROWTH-FACTORS AND ONCOGENES [J].
BASILICO, C ;
MOSCATELLI, D .
ADVANCES IN CANCER RESEARCH, 1992, 59 :115-165
[5]
BELLUS GA, 1995, AM J HUM GENET, V56, P368
[6]
Online Mendelian Inheritance in Man (OMIM) as a knowledgebase for human developmental disorders [J].
Boyadjiev, SA ;
Jabs, EW .
CLINICAL GENETICS, 2000, 57 (04) :253-266
[7]
CHELLAIAH AT, 1994, J BIOL CHEM, V269, P11620
[8]
Gly369Cys mutation in mouse FGFR3 causes achondroplasia by affecting both chondrogenesis and osteogenesis [J].
Chen, L ;
Adar, R ;
Yang, X ;
Monsonego, EO ;
Li, CL ;
Hauschka, PV ;
Yayon, A ;
Deng, CX .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (11) :1517-1525
[9]
Achondroplasia, hypochondroplasia and thanatophoric dysplasia: clinically related skeletal dysplasias that are also related at the molecular level [J].
Cohen, MM .
INTERNATIONAL JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY, 1998, 27 (06) :451-455
[10]
Skeletal overgrowth and deafness in mice lacking fibroblast growth factor receptor 3 [J].
Colvin, JS ;
Bohne, BA ;
Harding, GW ;
McEwen, DG ;
Ornitz, DM .
NATURE GENETICS, 1996, 12 (04) :390-397